Facebook In one of the first studies to examine this phenomenon, metabolically unhealthy obesity is associated with an increased risk, of around 1.5-fold higher, of any obesity-related cancer, and an even higher risk, of two- to threefold higher, for specific cancers, such as endometrial, liver, and renal cell cancers, compared with metabolically healthy normal weight. […]
Facebook DUBLIN (Reuters) – Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease as well as boosting weight loss, according to new research from the United States. After a year of taking semaglutide, marketed as Wegovy, patients’ risk of suffering from conditions like a heart attack or a stroke over […]
Facebook Researchers from Harvard Medical School found non-ictal cephalic allodynia, established by a quick, inexpensive and noninvasive proprietary test, is an 86% accurate pretreatment predictor of anti-calcitonin gene–related peptide (CGRP) therapy response. To read the rest of the article head over to PainMedicineNews.com More to explorer
